Strides Arcolab Receives FDA Approval for Generic Fluorouracil Injection
Bangalore-based pharmaceutical company Strides Arcolab revealed that it has received an approval from the US Food and Drug Administration for the manufacture of its generic Fluorouracil Injection for treating various cancers.
Recent figures released by IMS reveals that generic Fluorouracil has a market of over $14 million in the United States. Fluorouracil works by interfering in the function of the cells making DNA and RNA, thus preventing the spread of the cancer.
Strides Arcolab said that it has received approval to manufacture the drug in strengths of 50 mg / ml, packaged in 10 ml and 20 ml single-dose vials and 2.5 g/ 50 ml and 5 g / 100 ml pharmacy bulk packages.
P Introducing New Anti-Obesity Drugs Not the Solution to Rising Obesity Rates Genetic Blueprint of Single Sperm Cell Decoded M